I would like to raise three issues.
First, you mentioned the slower pace. We mentioned that there's already a provision of $7.7 billion to take into account the expected future improvements. Behind that number is that we are projecting a reduction of 40% in the mortality rates for those between the ages of 15 and 84, almost the same as over the last 40 years.
If you look at the work done, let's say at the international level, the country that is the most aggressive in terms of longevity improvements in the future is the U.K. It's doing that through what they call the continuous mortality investigation project. Although we are projecting that there will be almost the same number of people reaching age 90, the number of people reaching 100 will be very different. In other words, they have much more aggressive reduction in mortality rates for those between 85 and 100.
The point here is that it's very difficult for doctors and humanity to reduce mortality rates significantly at age 95. It's much more difficult than it is at age 65.